Cipla (EU), UK incorporates new wholly owned subsidiary in Germany
Advertisement
Mumbai: Cipla has announced that Cipla (EU) Limited, UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary named 'CiplaRna GmbH' in Germany.
The new entity was officially established on May 28, 2025, with the objective of establishing a laboratory for mRNA-based formulation and drug development support.
The company clarified that Cipla (EU) Limited has subscribed 25,000 shares of EUR 1 each at par.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.